Salus Deploys Medication Safety Platform in Large Academic Health System

Clinician-built technology moves from research, systemwide collaboration, to market

Mar. 31, 2026 at 6:05pm

Got story updates? Submit your updates here. ›

A translucent X-ray photograph revealing the intricate internal structure of a medical syringe or other healthcare equipment in glowing, ghostly lines against a dark background, conceptually representing the advanced technology used to identify medication risks earlier in the care process.Innovative technology enables earlier detection of medication risks, empowering clinicians to intervene and prevent patient harm.Houston Today

Salus, a healthcare technology company focused on medication safety, announced the enterprise deployment of its Medication Administration Protection System (MAPS) within Houston Methodist, a nationally recognized leader in clinical excellence, innovation, and technology-enabled care. The platform is being used as a live clinical solution designed to identify potential medication risks earlier in the care process.

Why it matters

Medication errors remain a persistent challenge across hospital settings, contributing to preventable patient harm and operational strain. While electronic medical records have improved ordering and documentation, many existing clinical decision support tools rely on static, rule-based alerts that may lack clinical context or surface risk too late to support timely intervention.

The details

The platform is powered by MAPSbrain, Salus' artificial intelligence engine developed specifically for clinical use. MAPSbrain applies natural language processing to unstructured clinical documentation—such as notes and medication instructions—alongside structured electronic medical record data. This approach enables the identification of complex medication risk scenarios that may not be captured by conventional rule-based systems. By synthesizing multiple data sources in real time, MAPS is designed to deliver context-aware alerts tailored to individual patient scenarios.

  • Salus announced the enterprise deployment of MAPS on March 31, 2026.

The players

Salus

A healthcare technology company focused on medication safety that developed the Medication Administration Protection System (MAPS).

Houston Methodist

A nationally recognized leader in clinical excellence, innovation, and technology-enabled care that is deploying the MAPS platform.

Dr. Brian Parrish

Co-Founder of Salus and Inventor of MAPS.

Dr. Luma Succar

Co-Founder of Salus and Co-Innovator of MAPS.

Roberta Schwartz

Executive vice president and chief innovation officer at Houston Methodist.

Got photos? Submit your photos here. ›

What they’re saying

“Medication safety tools often react too late or interrupt clinicians without context. This pilot shows real-time, EMR-embedded intelligence can identify risks earlier with greater precision. MAPS works with clinicians, not against them.”

— Dr. Brian Parrish, Co-Founder of Salus and Inventor of MAPS

“At Houston Methodist, we are committed to improving medication safety. Innovative tools enable our care teams to access actionable information at the moment it matters most.”

— Roberta Schwartz, Executive vice president and chief innovation officer at Houston Methodist

“Medication risk often emerges across fragmented pieces of the medical record. By interpreting clinical context as it unfolds, MAPS allows care teams to intervene earlier, with clearer insight and greater confidence.”

— Dr. Luma Succar, Co-Founder of Salus and Co-Innovator of MAPS

What’s next

Salus plans to continue expanding use of MAPS across additional health systems, building on insights gained from early enterprise deployments.

The takeaway

The deployment of Salus' MAPS platform at Houston Methodist demonstrates how clinician-built technology can leverage AI and natural language processing to identify medication risks earlier and with greater precision, empowering care teams to intervene and prevent patient harm.